NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Key Takeaways Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a ...

J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to ...

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, ...

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the ...

Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction ...

Quantbot Technologies LP cut its position in shares of Bausch Health Companies Inc. (NYSE:BHC – Free Report) by 95.7% in the ...

Bausch + Lomb has voluntarily recalled IOLs included on its enVista platform, including enVista Aspire, enVista Envy and ...

Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.

Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.

Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...